biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > This thread as become my new site for entertainment

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Mar 17, 2022 5:49pm

58 Views

Post# 34523444

RE:RE:RE:RE:RE:This thread as become my new site for entertainment

Go read your first post today. You took the first shot. I didn't initiate anything.

About being a jerk, all trolls think that people who challenge them are jerks. Whether I am a jerk or not, I will respond as I see fit. You certainly do that, and I will also, for 10 more years if I have to.

Smile, buddy. You just got challenged. And you don't know enough about Bioasis to talk about it. Your "short" post was nonsense.

jd

<< Previous

Bullboard Posts

Next >>

Southern Ontario mineral processing operation receives green fund support